## IBM: International Business Machines Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -0.7% below STRENGTH zone (4.0-10.0%); PEG 2.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($292.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Fisher Asset Management LLC Sells 2,729 Shares of International Business Machines Corporation $IBM**
- Source: MarketBeat | 20251205T091515 | Somewhat-Bullish | Relevance: 100%
- Fisher Asset Management LLC reduced its stake in International Business Machines (IBM) by 13% in Q2, selling 2,729 shares, but still holds 18,301 shares valued at $5.395 million. IBM recently exceeded quarterly earnings expectations, reporting EPS of $2.65 and revenue of $16.33 billion, and declared a quarterly dividend of $1.68. The company has a "Moderate Buy" consensus rating from analysts with an average target price of $291.08.

**2. TCM Advisors LLC Lowers Holdings in International Business Machines Corporation $IBM**
- Source: MarketBeat | 20251205T141046 | Somewhat-Bullish | Relevance: 100%
- TCM Advisors LLC significantly reduced its stake in International Business Machines Corporation (NYSE:IBM) by 54.3% in the second quarter, selling 3,800 shares and retaining 3,200 shares valued at approximately $943,000. Despite this, other major institutions like Norges Bank, GQG Partners, and Nuveen opened substantial new positions, and Vanguard increased its holdings to over 95 million shares. IBM reported strong quarterly earnings, beating estimates with an EPS of $2.65 and revenue of $16.33 billion, and declared a quarterly dividend of $1.68.

**3. Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis**
- Source: Finviz | 20251205T085645 | Bullish | Relevance: 100%
- IBM and Bayer 04 Leverkusen are collaborating to develop AI-powered solutions that enhance game analysis in professional football. Their new platform leverages IBM watsonx.ai and IBM Cloud to automate video analysis, reducing manual effort and providing data-driven insights. This innovation aims to optimize decision-making for analysts, scouts, and teams, fostering a data-driven future for the sport.

**4. Will IBM Cloud Powering Zyphraâ€™s AMD-Based Frontier AI Training Change International Business Machines' (IBM) Narrative?**
- Source: Simply Wall Street | 20251205T062632 | Somewhat-Bullish | Relevance: 100%
- IBM Cloud's role in Zyphra's frontier AI training, using an AMD-based platform for ZAYA1, reinforces IBM's relevance in high-performance AI. While this collaboration highlights IBM Cloud's capabilities, it doesn't fundamentally alter IBM's near-term investment narrative which remains focused on hybrid cloud and AI software growth. The key challenge for IBM is demonstrating that these high-profile AI wins translate into significant revenue and margin contributions to support its growth thesis against existing legacy pressures and a high debt load.

**5. International Business Machines Corporation (IBM): A Bull Case Theory**
- Source: Finviz | 20251204T120300 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on IBM, focusing on its 2027 quantum roadmap and modularization strategy. IBM aims to deliver a 1,080-qubit processor and a modular entanglement system, creating a hybrid quantum-classical computing ecosystem with accessible quantum tools for scientists. The company's stock has appreciated significantly since previous coverage, with its AI capabilities and quantum advancements being key drivers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Oppenheimer | $360 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Oppenheimer | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($1.06M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (+0.8%)
- Blackrock Inc.: 8.2% (-1.1%)
- State Street Corpora: 5.8% (-0.1%)
- JPMORGAN CHASE & CO: 3.6% (+49.8%)
- Geode Capital Manage: 2.4% (+1.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.08 elevated, pricing in significant growth expectations. Forward P/E 25.3x stretched relative to 7% growth. Quality metrics strong (ROE 30%). Balance sheet: $2.5B free cash flow. Insider buying signal ($1.1M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $285.2B |
| Beta | 0.69 |
| 52W Range | $214.50 - $324.90 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.08 |
| Forward P/E | 25.3 |
| Current P/E | 27.1 |
| YoY Growth | 7.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.5% over 5 days). Below STRENGTH zone by 4.7pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.71% (CS: 48) | Neutral |
| RSI_14 | 57.0 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.151x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $307.94
- **Stop Loss:** $292.02 (5.2% risk)
- **Target:** $323.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 62
- **Position Value:** $19,092.28
- **Portfolio %:** 19.09%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-28 (Est: $4.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.45 | $2.65 | +8.3% |
| 2025Q2 | $2.65 | $2.80 | +5.5% |
| 2025Q1 | $1.43 | $1.60 | +12.1% |
| 2024Q4 | $3.78 | $3.92 | +3.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*